Free Trial

Owens & Minor, Inc. (NYSE:OMI) Receives Average Rating of "Hold" from Analysts

Owens & Minor logo with Medical background

Key Points

  • Owens & Minor, Inc. has received a consensus rating of "Hold" from five research firms, with one sell recommendation, two holds, and two buys.
  • The stock's average 12-month price target is $11.60, despite having recently seen a significant drop of 4.6% in share value.
  • Institutional investors control 98.04% of the company's stock, with several investors significantly increasing their stakes in the last quarter.
  • MarketBeat previews top five stocks to own in September.

Owens & Minor, Inc. (NYSE:OMI - Get Free Report) has received a consensus rating of "Hold" from the five research firms that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and two have given a buy recommendation to the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $11.60.

OMI has been the topic of a number of recent analyst reports. Citigroup lowered their target price on shares of Owens & Minor from $13.00 to $11.00 and set a "buy" rating on the stock in a report on Thursday, April 17th. Robert W. Baird boosted their target price on shares of Owens & Minor from $9.00 to $10.00 and gave the stock a "neutral" rating in a report on Friday, June 6th.

View Our Latest Analysis on Owens & Minor

Owens & Minor Stock Down 4.6%

Owens & Minor stock opened at $6.61 on Friday. The company has a market cap of $510.62 million, a P/E ratio of -1.39, a price-to-earnings-growth ratio of 0.29 and a beta of 1.04. Owens & Minor has a 1-year low of $6.07 and a 1-year high of $16.63. The company has a fifty day simple moving average of $7.79 and a 200 day simple moving average of $8.46. The company has a current ratio of 1.13, a quick ratio of 0.41 and a debt-to-equity ratio of 3.32.

Owens & Minor (NYSE:OMI - Get Free Report) last released its earnings results on Saturday, May 10th. The company reported $0.23 earnings per share for the quarter, beating analysts' consensus estimates of $0.20 by $0.03. Owens & Minor had a negative net margin of 3.41% and a positive return on equity of 17.09%. The company's revenue was up .7% compared to the same quarter last year. During the same period in the prior year, the company earned $0.19 earnings per share. Research analysts anticipate that Owens & Minor will post 1.51 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Owens & Minor

A number of large investors have recently added to or reduced their stakes in OMI. Sterling Capital Management LLC raised its stake in Owens & Minor by 758.3% in the 4th quarter. Sterling Capital Management LLC now owns 2,060 shares of the company's stock valued at $27,000 after acquiring an additional 1,820 shares during the period. DekaBank Deutsche Girozentrale raised its stake in Owens & Minor by 76.6% in the 2nd quarter. DekaBank Deutsche Girozentrale now owns 3,126 shares of the company's stock valued at $28,000 after acquiring an additional 1,356 shares during the period. Versant Capital Management Inc raised its stake in Owens & Minor by 537.6% in the 1st quarter. Versant Capital Management Inc now owns 3,201 shares of the company's stock valued at $29,000 after acquiring an additional 2,699 shares during the period. Parallel Advisors LLC raised its stake in Owens & Minor by 1,387.0% in the 1st quarter. Parallel Advisors LLC now owns 3,316 shares of the company's stock valued at $30,000 after acquiring an additional 3,093 shares during the period. Finally, Quarry LP bought a new stake in Owens & Minor in the 1st quarter valued at $34,000. Institutional investors own 98.04% of the company's stock.

About Owens & Minor

(Get Free Report

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.

Recommended Stories

Analyst Recommendations for Owens & Minor (NYSE:OMI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Owens & Minor Right Now?

Before you consider Owens & Minor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Owens & Minor wasn't on the list.

While Owens & Minor currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir & AMD Earnings: Massive Options Setups Ahead
3 Value Plays Set to Explode
5 Stocks to BUY NOW in August 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines